lifestyle.thenyctimes.com

Author: Faron Pharmaceuticals

Faron Pharmaceuticals Ltd: Director Dealing

March 31, 2026
Faron Pharmaceuticals Ltd: Faron Appoints New CTO to Strengthen Late-Stage Development Activities

March 26, 2026
Faron Pharmaceuticals Ltd: Director Dealing

March 19, 2026
Faron Pharmaceuticals Ltd: Holding(s) in Company

March 12, 2026
Update to Faron’s Financial Calendar and Date of the Annual General Meeting in 2026

March 9, 2026
CORRECTION: Faron Pharmaceuticals Ltd’s Annual Report 2025 published

March 4, 2026
Faron’s Financial Statements Release 1 January to 31 December 2025

March 4, 2026
Faron Pharmaceuticals Ltd’s Annual Report 2025 Published

March 4, 2026
Faron Pharmaceuticals Ltd: Results of the Extraordinary General Meeting

March 2, 2026
Faron and City of Hope in Process of Developing a Phase II Investigator-Initiated Trial of Bexmarilimab in Relapsed/Refractory MDS

March 2, 2026